{"id":16057,"date":"2020-07-09T06:38:58","date_gmt":"2020-07-09T06:38:58","guid":{"rendered":"https:\/\/dailyhomeland.com\/?p=16057"},"modified":"2020-07-09T06:38:58","modified_gmt":"2020-07-09T06:38:58","slug":"u-s-steps-up-covid-19-vaccines-therapies-development","status":"publish","type":"post","link":"https:\/\/dailyhomeland.com\/?p=16057","title":{"rendered":"U.S. steps up COVID-19 vaccines, therapies development"},"content":{"rendered":"<p>As the confirmed COVID-19 cases surpassed 3 million in the country, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced the establishment of a new clinical trials network on Wednesday aiming to step up vaccines and monoclonal antibodies testing.<\/p>\n<p>The new network, called the COVID-19 Prevention Trials Network, will enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies.<\/p>\n<p>&#8220;Starting this summer, this new network will leverage existing infrastructure and engage communities to secure the thousands of volunteers needed for late-stage clinical trials of promising vaccines,&#8221; said U.S. Secretary of Health and Human Services Alex Azar.<\/p>\n<p>&#8220;Having a safe and effective medical countermeasure to prevent COVID-19 would enable us to not only save lives but also help end the global pandemic,&#8221; said NIAID Director Anthony Fauci.<\/p>\n<p>&#8220;Starting this summer, this new network will leverage existing infrastructure and engage communities to secure the thousands of volunteers needed for late-stage clinical trials of promising vaccines,&#8221; said U.S. Secretary of Health and Human Services Alex Azar.<\/p>\n<p>&#8220;Having a safe and effective medical countermeasure to prevent COVID-19 would enable us to not only save lives but also help end the global pandemic,&#8221; said NIAID Director Anthony Fauci.<br \/>\nThe new network is expected to operate more than 100 clinical trial sites across the United States and internationally, according to the NIAID.<\/p>\n<p>It is part of ongoing efforts across the country in speeding up the development of vaccines and therapies against COVID-19.<\/p>\n<p>According to Fauci, the U.S. government will fund and conduct key studies on three experimental coronavirus vaccines in the summer.<\/p>\n<p>Phase 3 trials, which typically involve tens of thousands of people and measure whether a vaccine is safe and effective, will begin with one by Moderna in July, then an Oxford\/AstraZeneca vaccine in August and one by Johnson &amp; Johnson in September.<\/p>\n<p>Fauci said that the testing plans still track with the timeline that he has suggested in the past: a vaccine at scale by the end of the year or early next year.<\/p>\n<p>Remdesivir, the only drug that has an emergency use authorization from the U.S. Food and Drug Administration to treat COVID-19, has shown promising results and sets a new standard of care for COVID-19 patients.<\/p>\n<p>In order to expand the potential uses of the drug against SARS-CoV-2, American biopharmaceutical company Gilead Sciences has announced plans to explore administration of remdesivir in an inhaled form.<\/p>\n<p>According to Azar, more than 120,000 courses of remdesivir have been distributed to all of 50 states.<\/p>\n<p>More than 3,035,000 COVID-19 cases have been reported in the United States with the fatalities surpassing 132,000 as of Wednesday evening, according to a tally by Johns Hopkins University.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>As the confirmed COVID-19 cases surpassed 3 million in the country, the U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced the establishment of a new clinical trials network on Wednesday aiming to step up vaccines and monoclonal antibodies testing. The new network, called the COVID-19 Prevention Trials Network, will enroll thousands of volunteers [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16060,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","jetpack_publicize_message":"","jetpack_is_tweetstorm":false},"categories":[48,40,39],"tags":[],"jetpack_featured_media_url":"https:\/\/sgp1.digitaloceanspaces.com\/cosmosgroup\/news\/5775879_New%20Project%20(6).jpg","jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/16057"}],"collection":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16057"}],"version-history":[{"count":1,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/16057\/revisions"}],"predecessor-version":[{"id":16059,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/posts\/16057\/revisions\/16059"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=\/wp\/v2\/media\/16060"}],"wp:attachment":[{"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyhomeland.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}